Targeting the p300/CBP Axis in Lethal Prostate Cancer. (2021)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/2159-8290.cd-20-0751
PubMed Identifier: 33431496
Publication URI: http://europepmc.org/abstract/MED/33431496
Type: Journal Article/Review
Volume: 11
Parent Publication: Cancer discovery
Issue: 5
ISSN: 2159-8274